Novel crystalline form of (3-cyano-1H-indol-7-yl)-[4-(4-fluorophen ethyl)-piperazine-1-yl]-methanone hydrochloride

Details for Australian Patent Application No. 2005289169 (hide)

Owner Merck Patent GmbH

Inventors Helfert, Bernd; Saal, Christoph; Bathe, Andreas; Keiner, Ronald; Knierieme, Ralf

Agent Davies Collison Cave

Pub. Number AU-B-2005289169

PCT Pub. Number WO2006/034774

Priority 10 2004 047 517.2 28.09.04 DE

Filing date 8 September 2005

Wipo publication date 6 April 2006

Acceptance publication date 14 July 2011

International Classifications

C07D 209/42 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/034774 Priority application(s): WO2006/034774

14 July 2011 Application Accepted

  Published as AU-B-2005289169

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005289171-Method for compressing a natural gas flow

2005289164-Carbonyl compounds usable as coagulation factor Xa inhibitors